High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial
Open Access
- 1 July 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (1) , 123-130
- https://doi.org/10.1086/588792
Abstract
Background. The standard therapy for human immunodeficiency virus (HIV)–associated cryptococcal meningitis of amphotericin B (AmB; 0.7 mg/kg per day)Keywords
This publication has 32 references indexed in Scilit:
- Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or FluconazoleClinical Infectious Diseases, 2007
- Oral versus Intravenous Flucytosine in Patients with Human Immunodeficiency Virus-Associated Cryptococcal MeningitisAntimicrobial Agents and Chemotherapy, 2007
- Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapyAIDS, 2006
- Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1Blood, 2006
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Early Mycological Treatment Failure in AIDS‐Associated Cryptococcal MeningitisClinical Infectious Diseases, 1999
- Randomized Comparison of Amphotericin B Deoxycholate Dissolved in Dextrose or Intralipid for the Treatment of AIDS-Associated Cryptococcal MeningitisClinical Infectious Diseases, 1996
- Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short PeriodClinical Infectious Diseases, 1995
- Amphotericin B Blunts Erythropoietin Response to AnemiaThe Journal of Infectious Diseases, 1990
- Clinical Pharmacokinetics of Systemic Antifungal DrugsClinical Pharmacokinetics, 1983